02289nam a2200481 i 4500 283544 283544 on1107052444 OCoLC 20190816144455.0 m o d f cr ||||||||||| 190702s2019 dcu o f000 0 eng c 36-619 PUCPR eng rda pn GPO GPO MvI pcc n-us--- 1016-C (online) Y 4.OV 2:116-07 Serial no. 116-07 (United States. Congress. House. Committee on Oversight and Reform) Y 4.OV 2:116-07 United States. Congress. House. Committee on Oversight and Reform, Trump administration's response to the drug crisis : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 7, 2019. Washington : U.S. Government Publishing Office, 2019. 1 online resource (iii, 68 pages) txt c rdamedia cr rdacarrier "Serial no. 116-07." Access ID (govinfo): CHRG-116hhrg36619. CRDP Program record. Hearing witnesses: James W. Carroll, Jr., Office of National Drug Control Policy; Triana McNeil, Acting Director, Strategic Issues, Government Accountability Office; Mike McDaniel, Director, Houston High Intensity Drug Trafficking Area. Date of hearing: 2019-03-07. Description based on online resource; title from PDF title page (govinfo, viewed July 2, 2019). Print version: United States. Congress. House. Committee on Oversight and Reform. Trump administration's response to the drug crisis (OCoLC)1107265485 PDF version https://purl.fdlp.gov/GPO/gpo122680 Text version https://purl.fdlp.gov/GPO/gpo122681 KF27 .O96 2019e United States. Office of National Drug Control Policy Customer services. Drug control United States. Opioid abuse United States. Opioids Overdose United States Prevention. Legislative hearings. lcgft sudocs 8 0 0 sudocs 0 Y_4OV_211607 0 412768 7 7 55 2019-08-16 0 Y 4.OV 2:116-07 Y 4.OV 2:116-07 2019-08-16 00:00:00 1 2019-08-16 8